Draw/line
Education and research purposes only, not medical advice. Unapproved compounds are not for human consumption. Check every result with your prescriber. Disclaimer Research and education only. Not medical advice. Disclaimer
Home / Compounds / P21

P21

P21 (P021): a CNTF-derived experimental peptide studied only in mice for memory, its legal status, the evidence gap and sport rules.

Not approved, animal data only · Evidence grade D · Reviewed

Not approved by the FDA for human use. Not for human consumption. This page describes P21 only to explain its regulatory status, what has been studied and its known risks. Drawline does not recommend obtaining or using it. Disclaimer

Approved and studied uses
  • Not approvedMemoryMouse data only; never tested in people
Training and drug testingBanned at all times

It is not named on the WADA Prohibited List, but no health authority has approved it for human use, so it falls under class S0 (non-approved substances), banned at all times.

Drug-tested athletes can look up any substance on Global DRO, run by national anti-doping agencies. Supplements can contain banned substances that are not on the label. Drawline does not suggest when to train or inject.

P21 (P021, P-021, CNTF-derived peptide). Experimental neurotrophic peptide.

DNot approved, animal data only. Evidence grade D: animal and lab data only.

What is P21?

P21 (P021) is a small experimental compound based on a fragment of ciliary neurotrophic factor (CNTF), with an adamantylated glycine added to help it cross into the brain and resist breakdown. It was developed by Khalid Iqbal's laboratory at the New York State Institute for Basic Research in Developmental Disabilities.

Is P21 FDA-approved?

Not approved for any use, and no drug application or human trial for it has been reported. It was not among the peptides FDA reviewed for compounding in July 2026. Products sold online for memory or focus are unapproved research chemicals.

What does the evidence show for P21?

Only animal and lab studies, mainly in mouse models of Alzheimer's disease and Down syndrome, where it improved memory tests and new nerve cell growth. The developers' own 2022 review states it has not been tested in humans.

What are the known risks of P21?

Its effects and safety in people are unknown. Mouse results for brain diseases often fail to carry over to humans. Products sold online have no assurance of identity, dose or purity. Sport: it is not named on the WADA Prohibited List, but no health authority has approved it for human use, so it falls under class S0 (non-approved substances), banned at all times.

How is P21 measured?

A powder vial: enter the amount in the vial and the water added, and the calculator shows the syringe units for a prescribed dose. Products sold online as "research use only" have no assurance of identity, dose or sterility. The calculator can do the arithmetic for any vial, but it cannot tell you what is actually in one.

Sources: Baazaoui and Iqbal, P021 prevents synaptic deficits in mice (2017); Baazaoui and Iqbal, review of P021 (2022); Alzheimer's Drug Discovery Foundation: P021 evidence summary; WADA: 2026 Prohibited List. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.

Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.